Literature DB >> 8549406

Oral ciprofloxacin vs intravenous therapy with nonquinolone agents. A study of 291 infections.

V Lorian1, K Pavletich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8549406     DOI： 10.2165/00003495-199500492-00141

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  4 in total

1.  Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial.

Authors:  L O Gentry; C H Ramirez-Ronda; E Rodriguez-Noriega; H Thadepalli; P L del Rosal; C Ramirez
Journal:  Arch Intern Med       Date:  1989-11

2.  Intravenous and oral ciprofloxacin versus intravenous ceftazidime for the treatment of severe urinary tract infections.

Authors:  S J Childs
Journal:  Diagn Microbiol Infect Dis       Date:  1990 Mar-Apr       Impact factor: 2.803

3.  Economic impact of oral ciprofloxacin following standard intravenous therapy.

Authors:  R M Fliegelman; P M Mattingly; C L Dempsey; S J Sokalski
Journal:  Diagn Microbiol Infect Dis       Date:  1990 Mar-Apr       Impact factor: 2.803

4.  Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics.

Authors:  J A Paladino; H E Sperry; J M Backes; J A Gelber; D J Serrianne; T J Cumbo; J J Schentag
Journal:  Am J Med       Date:  1991-11       Impact factor: 4.965
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.